Columbus, Ohio Event Leads Way for African American Myeloma Patients
Rabbit Virus Eliminates Myeloma Cells In Mouse Models
The Latest in Amyloidosis Research With Heather Landau, MD, Memorial Sloan Kettering Cancer Center
Many multiple myeloma patients can also have amyloidosis - or protein buildup in specific organs. Dr. Heather Landau of the Memorial Sloan Kettering...
Riding the Myeloma Roller Coaster Part 1: Expert Tips on How to Cope
FDA Approves Lenalidomide (Revlimid) As Maintenance Therapy Post-Transplant
Takeda Teams Up With PatientsLikeMe for a Myeloma Patient Survey
Clinical Trial: "Cleaning Up" Stem Cells Before They are Given Back During Stem Cell Transplant
Your Myeloma Meds: Managing Those Side Effects
Allogeneic Transplant for Young, High-Risk Myeloma Patients with Dr. Cristina Gasparetto, MD, Duke Medical Center
Allogeneic stem cell transplant can be selectively and successfully used for young and high-risk myeloma patients. Allo transplant is considered the "first...
Peripheral Neuropathy and Multiple Myeloma: Not Just Feet and Hands
Myeloma 101: The Difference Between Consolidation and Maintenance Therapy
Natural Killer Cells Can Be Used With Standard Myeloma Therapies
Be Careful What You Wish For: My Chemo Diet
Lenalidomide (Revlimid) Maintenance Post-Transplant is Approved in Europe
Clinical Trial: Vaccine Plus Stem Cell Transplant for Newly Diagnosed or Relapsed Myeloma Patients
Lenalidomide (Revlimid) Financial Assistance Program
Ixazomib (Ninlaro) Financial Assistance Program
Daratumumab (Darzalex) Financial Assistance Program
Clinical Trial: Can Myeloma Combo Therapies Plus Today's Standard Care Help Myeloma Patients with Solitary Plasmacytoma of the Bone?
Minimal Residual Disease Testing and Why It Matters to Myeloma Patients with Dr. Ola Landgren, MD, PhD, MSKCC
Minimal Residual Disease testing has become a buzz word in multiple myeloma. What exactly does it mean? In this show Dr. Ola Landgren...
Myeloma Progress and Where We're Headed Next with Robert Orlowski, MD, PhD, MD Anderson Cancer Center
The year 2017 promises to be another exciting one in multiple myeloma. Dr. Robert Orlowski shares key developments from last year...
Ask the Myeloma Experts - Patient Questions from the St. Louis Myeloma Crowd Round Table Meeting
It's a rare opportunity to have a panel of myeloma experts available to answer any patient question that may be asked. Experts at our Myeloma Crowd Round...
Diet and Multiple Myeloma (Part 4): Toasting the New Year
Diet and Myeloma Part 3: You’ve Got to Accentuate the Positive, Eliminate the Negative…
